Albany, US – DelveInsight has launched its new report on Vitiligo Market Insights, Epidemiology and Market Forecast-2030
DelveInsight’s “Vitiligo – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Vitiligo, historical and forecasted epidemiology as well as the Vitiligo market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Key facts of the report:1. The prevalent population of Vitiligo in the 7MM was approximately 6,234,655 in 2017.2. The U.S. accounted for the highest prevalent cases with around 2,663,753 cases in 2017.3. Among the EU5, Germany has the highest prevalent population of Vitiligo with approximately 472,057 cases followed by the UK, which has a prevalent population of approximately 290,965 in 2017.4. France was accounted for the lowest number of prevalent cases, among EU5 countries, with around 188,196 cases in 2017.
Report Highlights:1. In the coming years, Vitiligo market is set to change due to the rising awareness of the disease, and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market2. The companies and academics are working to assess challenges and seek opportunities that could influence Vitiligo R&D. The therapies under development are focused on novel approaches to treat/improve the disease condition 3. Major players are involved in developing therapies for Vitiligo. Launch of emerging therapies will significantly impact the Vitiligo market4. A better understanding of disease pathogenesis will also contribute to the development of novel therapeutics for Vitiligo
Request for sample pages: https://www.delveinsight.com/sample-request/vitiligo-market
“The main symptom of Vitiligo is flat, white spots or patches on the skin. Gradually the patch will become completely white. Sometimes the centre of a patch may be white with pale skin around it.”
Many researchers have identified several forms of Vitiligo. Generalized Vitiligo (also called non-segmental Vitiligo), which is the most common form, involves loss of pigment (depigmentation) in patches of skin all over the body. Another form called segmental Vitiligo (also known as unilateral or localized Vitiligo) is associated with smaller patches of depigmented skin that appear on one side of the body in a limited area; this occurs in about 10% of affected individuals.
The key pharma players involved in Vitiligo market are:1. Incyte Corporation2. Clinuvel Pharmaceutical3. Aclaris Therapeutics4. Celgene5. Pfizer
The emerging drug therapies boosting the Vitiligo treatment are:1. INCB0184242. SCENESSE (afamelanotide)And many others
Download a free sample report on Vitiligo @https://www.delveinsight.com/sample-request/vitiligo-market
Table of Contents:1. Key Insights2. Vitiligo Market Overview at a Glance3. Vitiligo Disease Background and Overview4. Vitiligo Epidemiology and Patient Population5. United States Vitiligo Epidemiology6. EU5 Epidemiology of Vitiligo6.1. Assumptions and Rationale6.2. Germany6.3. France6.4. Italy6.5. Spain6.6. United Kingdom7. Japan Epidemiology of Vitiligo8. Vitiligo Treatment Algorithm9. Unmet Needs10. Vitiligo Emerging Therapies10.1. INCB018424: Incyte Corporation10.2. SCENESSE (afamelanotide): Clinuvel Pharmaceutical11. Other Promising Candidates11.1. ATI?50002: Aclaris Therapeutics11.2. Apremilast: Celgene11.3. PF?06700841 and PF?06651600: Pfizer12. Vitiligo: 7 Major Market Analysis13. The United States: Market Outlook13.1.United States Market Size14. EU5 Countries: Market Outlook14.1.Germany Market Size14.2. France Market Size14.3. Italy Market Size14.4. Spain Market Size14.5. The United Kingdom Market size15. Japan: Market Outlook15.1.Japan: Market Size16. Market Drivers and Market Barriers17. DelveInsight Capabilities18. Disclaimer19. About DelveInsight
Related Reports:
Vitiligo – Epidemiology Forecast to 2030
Vitiligo Pipeline Insight, 2020
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Priya MauryaEmail: Send EmailPhone: 9193216187Address:304 S. Jones Blvd #2432 City: AlbanyState: New YorkCountry: United StatesWebsite: https://www.delveinsight.com/